HYPERION DEFI, INC. (HYPD) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
19/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseHYPD / S&P -8.99% / 15.20% |
LoseHYPD / S&P HYPD unavailable / 15.00% |
LoseHYPD / S&P -78.71% / 50.40% |
| 2026-Q11/3 |
WinHYPD / S&P -3.09% / -4.33% |
LoseHYPD / S&P HYPD unavailable / 11.30% |
LoseHYPD / S&P -77.80% / 27.70% |
| 2025-Q40/3 |
LoseHYPD / S&P -62.84% / 2.65% |
LoseHYPD / S&P HYPD unavailable / 9.00% |
LoseHYPD / S&P -80.96% / 13.40% |
| 2025-Q30/3 |
LoseHYPD / S&P -7.71% / 8.12% |
LoseHYPD / S&P HYPD unavailable / 4.61% |
LoseHYPD / S&P -77.81% / 13.45% |
| 2025-Q21/3 |
WinHYPD / S&P 843.64% / 10.94% |
LoseHYPD / S&P HYPD unavailable / 4.83% |
LoseHYPD / S&P -65.24% / 10.63% |
| 2025-Q10/3 |
LoseHYPD / S&P -90.58% / -4.27% |
LoseHYPD / S&P HYPD unavailable / 4.98% |
LoseHYPD / S&P -37.52% / 10.57% |
| 2024-Q41/3 |
LoseHYPD / S&P -71.76% / 2.41% |
LoseHYPD / S&P HYPD unavailable / 5.25% |
WinHYPD / S&P 16.64% / 6.15% |
| 2024-Q31/3 |
LoseHYPD / S&P -12.96% / 5.89% |
LoseHYPD / S&P HYPD unavailable / 5.89% |
WinHYPD / S&P 14841.54% / 6.11% |
| 2024-Q21/3 |
LoseHYPD / S&P -39.76% / 4.28% |
LoseHYPD / S&P HYPD unavailable / 5.38% |
WinHYPD / S&P 12875.00% / 5.12% |
| 2024-Q11/3 |
LoseHYPD / S&P -52.60% / 10.56% |
LoseHYPD / S&P HYPD unavailable / 5.71% |
WinHYPD / S&P 9594.59% / 5.59% |
| 2023-Q42/3 |
WinHYPD / S&P 25.30% / 11.69% |
LoseHYPD / S&P HYPD unavailable / 6.81% |
WinHYPD / S&P 6302.41% / 7.78% |
| 2023-Q31/3 |
LoseHYPD / S&P -29.96% / -3.27% |
LoseHYPD / S&P HYPD unavailable / 7.52% |
WinHYPD / S&P 18.18% / -5.03% |
| 2023-Q21/3 |
LoseHYPD / S&P -32.86% / 8.74% |
LoseHYPD / S&P HYPD unavailable / 9.50% |
WinHYPD / S&P 23.64% / -8.57% |
| 2023-Q12/3 |
WinHYPD / S&P 116.56% / 7.50% |
LoseHYPD / S&P HYPD unavailable / 10.77% |
WinHYPD / S&P 42.31% / -15.69% |
| 2022-Q41/3 |
LoseHYPD / S&P -16.62% / 7.56% |
LoseHYPD / S&P HYPD unavailable / 11.88% |
WinHYPD / S&P 69.39% / -17.99% |
| 2022-Q31/3 |
WinHYPD / S&P 0.26% / -4.88% |
LoseHYPD / S&P HYPD unavailable / 13.47% |
LoseHYPD / S&P -27.63% / -1.41% |
| 2022-Q20/3 |
LoseHYPD / S&P -36.07% / -16.10% |
LoseHYPD / S&P HYPD unavailable / 13.71% |
LoseHYPD / S&P -29.49% / 11.04% |
| 2022-Q10/3 |
LoseHYPD / S&P -23.75% / -4.60% |
LoseHYPD / S&P HYPD unavailable / 15.97% |
LoseHYPD / S&P HYPD unavailable / 42.23% |
| 2021-Q40/3 |
LoseHYPD / S&P -18.37% / 11.03% |
LoseHYPD / S&P HYPD unavailable / 15.00% |
LoseHYPD / S&P HYPD unavailable / 96.40% |
| 2021-Q30/3 |
LoseHYPD / S&P -1.21% / 0.58% |
LoseHYPD / S&P HYPD unavailable / 10.77% |
LoseHYPD / S&P HYPD unavailable / 69.42% |
| 2021-Q20/3 |
LoseHYPD / S&P -2.94% / 8.55% |
LoseHYPD / S&P HYPD unavailable / 6.58% |
LoseHYPD / S&P HYPD unavailable / 51.81% |
| 2021-Q10/3 |
LoseHYPD / S&P -15.68% / 6.17% |
LoseHYPD / S&P HYPD unavailable / -1.06% |
LoseHYPD / S&P HYPD unavailable / 7.39% |
| 2020-Q41/3 |
WinHYPD / S&P 94.23% / 12.15% |
LoseHYPD / S&P HYPD unavailable / -3.72% |
LoseHYPD / S&P HYPD unavailable / -33.42% |
| 2020-Q31/3 |
WinHYPD / S&P 9.86% / 8.93% |
LoseHYPD / S&P HYPD unavailable / -2.04% |
LoseHYPD / S&P HYPD unavailable / -27.10% |
| 2020-Q21/3 |
WinHYPD / S&P 23.48% / 20.54% |
LoseHYPD / S&P HYPD unavailable / -0.46% |
LoseHYPD / S&P HYPD unavailable / -27.11% |
| 2020-Q10/3 |
LoseHYPD / S&P -48.66% / -19.60% |
LoseHYPD / S&P HYPD unavailable / 3.47% |
LoseHYPD / S&P HYPD unavailable / -14.75% |
| 2019-Q41/3 |
WinHYPD / S&P 21.08% / 9.07% |
LoseHYPD / S&P HYPD unavailable / 5.36% |
LoseHYPD / S&P HYPD unavailable / 2.99% |
| 2019-Q30/3 |
LoseHYPD / S&P -13.95% / 1.70% |
LoseHYPD / S&P HYPD unavailable / 5.02% |
LoseHYPD / S&P HYPD unavailable / 0.21% |
| 2019-Q20/3 |
LoseHYPD / S&P -28.21% / 4.30% |
LoseHYPD / S&P HYPD unavailable / 6.64% |
LoseHYPD / S&P HYPD unavailable / 8.65% |
| 2019-Q11/3 |
WinHYPD / S&P 110.18% / 13.65% |
LoseHYPD / S&P HYPD unavailable / 8.12% |
LoseHYPD / S&P HYPD unavailable / 14.29% |
| 2018-Q40/3 |
LoseHYPD / S&P -29.10% / -13.52% |
LoseHYPD / S&P HYPD unavailable / 9.05% |
LoseHYPD / S&P HYPD unavailable / 18.23% |
| 2018-Q30/3 |
LoseHYPD / S&P -36.19% / 7.71% |
LoseHYPD / S&P HYPD unavailable / 10.21% |
LoseHYPD / S&P HYPD unavailable / 19.06% |
| 2018-Q20/3 |
LoseHYPD / S&P -31.15% / 3.43% |
LoseHYPD / S&P HYPD unavailable / 9.03% |
LoseHYPD / S&P HYPD unavailable / 14.46% |
| 2018-Q10/3 |
LoseHYPD / S&P HYPD unavailable / -0.76% |
LoseHYPD / S&P HYPD unavailable / 7.68% |
LoseHYPD / S&P HYPD unavailable / 12.46% |
| 2017-Q40/3 |
LoseHYPD / S&P HYPD unavailable / 6.64% |
LoseHYPD / S&P HYPD unavailable / 7.03% |
LoseHYPD / S&P HYPD unavailable / 13.82% |
| 2017-Q30/3 |
LoseHYPD / S&P HYPD unavailable / 4.48% |
LoseHYPD / S&P HYPD unavailable / 5.68% |
LoseHYPD / S&P HYPD unavailable / 17.57% |
| 2017-Q20/3 |
LoseHYPD / S&P HYPD unavailable / 3.09% |
LoseHYPD / S&P HYPD unavailable / 4.83% |
LoseHYPD / S&P HYPD unavailable / 17.74% |
| 2017-Q10/3 |
LoseHYPD / S&P HYPD unavailable / 6.07% |
LoseHYPD / S&P HYPD unavailable / 3.67% |
LoseHYPD / S&P HYPD unavailable / 13.32% |
| 2016-Q40/3 |
LoseHYPD / S&P HYPD unavailable / 3.82% |
LoseHYPD / S&P HYPD unavailable / 2.09% |
LoseHYPD / S&P HYPD unavailable / 7.05% |
| 2016-Q30/3 |
LoseHYPD / S&P HYPD unavailable / 3.85% |
LoseHYPD / S&P HYPD unavailable / 0.20% |
LoseHYPD / S&P HYPD unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | HYPD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -40.66% | 20.78% |
| Annualized return | -40.66% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | HYPD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.20% | 83.14% |
| Annualized return | -61.91% | 12.86% |
10Y · 2018-01-25 to 2026-08-27
| Metric | HYPD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.54% | 319.30% |
| Annualized return | -41.67% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |